Decreased vesicular acetylcholine transporter related to memory deficits in epilepsy: A [18F] VAT positron emission tomography brain imaging study

被引:7
|
作者
Wu, Xu-Qing [1 ]
Zhao, Ya-Nan [1 ]
Ding, Jing [1 ]
Si, Zhan [2 ]
Cheng, Deng-Feng [2 ]
Shi, Hong-Cheng [2 ]
Wang, Xin [1 ,3 ,4 ]
机构
[1] Fudan Univ, Dept Neurol, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Dept Nucl Med, Zhongshan Hosp, Shanghai, Peoples R China
[3] Fudan Univ, State Key Lab Med Neurobiol, Inst Brain Sci, Shanghai, Peoples R China
[4] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
epilepsy; memory deficit; positron emission tomography; vesicular acetylcholine transporter; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; HIPPOCAMPAL NEUROGENESIS; COGNITIVE IMPAIRMENT; CHOLINERGIC NEURONS; ALZHEIMERS-DISEASE; SPATIAL MEMORY; VERBAL MEMORY; SEIZURE; EXPRESSION;
D O I
10.1111/epi.14533
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveVesicular acetylcholine transporter (VAChT) is a rate-limiting factor for synaptic acetylcholine transport. Our study focused on whether [F-18] VAT, a novel positron emission tomography (PET) tracer, could be used in detecting cognitive deficits in epilepsy. MethodsMorris water maze test was used to evaluate learning and memory deficits in pilocarpine-induced chronic epilepsy rats 12 weeks after status epilepticus. Interictal [F-18] VAT PET was performed 13 weeks after status epilepticus to evaluate the level of VAChT in cholinergic pathways compared with [F-18] fluorodeoxyglucose PET. The association between VAChT levels and memory measures was analyzed. Neuropathological tests were performed. ResultsEpileptic rats exhibited significant memory deficits in Morris water maze test. [F-18] VAT uptake decreased in septum, hippocampus, thalamus, and basal forebrain, and correlated to memory function. Of note, the level of VAChT in basal forebrain significantly decreased, yet no glucose hypometabolism was detected. Immunofluorescence and Western blot demonstrated decreased expression of VAChT in hippocampus and basal forebrain in the epilepsy group, but no change of expression of acetyltransferase or activity of acetylcholinesterase was detected. Significance[F-18] VAT PET is a promising method to test the level of VAChT as a valuable biomarker for memory deficits in pilocarpine-induced chronic epileptic rats.
引用
收藏
页码:1655 / 1666
页数:12
相关论文
共 50 条
  • [41] Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer
    Haihao Sun
    Andrew Sloan
    Thomas J. Mangner
    Ulka Vaishampayan
    Otto Muzik
    Jerry M. Collins
    Kirk Douglas
    Anthony F. Shields
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 15 - 22
  • [42] [18F] fluorodeoxyglucose positron-emission tomography-CT imaging of carotidynia
    Amaravadi, R. R.
    Behr, S. C.
    Kousoubris, P. D.
    Raja, S.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) : 1197 - 1199
  • [43] Hypoxia and glucose metabolism in malignant tumors:: Evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging
    Rajendran, JG
    Mankoff, DA
    O'Sullivan, F
    Peterson, LM
    Schwartz, DL
    Conrad, EU
    Spence, AM
    Muzi, M
    Farwell, DG
    Krohn, KA
    CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2245 - 2252
  • [44] Positron emission tomography with [18F]FDOPA and [18F]FDG in the imaging of small cell lung carcinoma: preliminary results
    Thierry Jacob
    Dany Grahek
    Nassima Younsi
    Khaldoun Kerrou
    Nicolas Aide
    Françoise Montravers
    Sonia Balogova
    Cecile Colombet
    Virginie de Beco
    Jean N. Talbot
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1266 - 1269
  • [45] Positron emission tomography with [18F]FDOPA and [18F]FDG in the imaging of small cell lung carcinoma:: preliminary results
    Jacob, T
    Grahek, D
    Younsi, N
    Kerrou, K
    Aide, N
    Montravers, F
    Balogova, S
    Colombet, C
    de Beco, V
    Talbot, JN
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (09) : 1266 - 1269
  • [46] Comparison of [18F]-FDG and [18F]-NaF Positron Emission Tomography on Culprit Carotid Atherosclerosis A Prospective Study
    Kim, Jeong-Min
    Lee, Eun Seong
    Park, Kwang-Yeol
    Seok, Ju Won
    Kwon, Oh-Sang
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (02) : 370 - 372
  • [47] Novel [18F]-Labeled Meta-Bromobenzylguanidine Derivatives: Potential Positron Emission Tomography Imaging Probes for the Norepinephrine Transporter
    Li, Xiaoyan
    Shi, Shuyu
    Zhou, Hang
    Zhao, Zuoquan
    Lu, Jie
    MOLECULAR PHARMACEUTICS, 2021, 18 (10) : 3811 - 3819
  • [48] In vivo imaging of Lyme arthritis in mice by [18F]fluorodeoxyglucose positron emission tomography/computed tomography
    Pietikainen, A.
    Siitonen, R.
    Liljenback, H.
    Eskola, O.
    Soderstrom, M.
    Roivainen, A.
    Hytonen, J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (01) : 37 - 47
  • [49] Fluorine-18-radiolabeled pharmaceuticals for imaging with positron emission tomography, excluding [18F]-fluorodeoxyglucose
    Pauwels, EKJ
    van der Klaauw, AA
    Corporaal, T
    Stokkel, MPM
    DRUGS OF THE FUTURE, 2002, 27 (07) : 655 - 667
  • [50] Evaluation of [18F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function
    Yagi, Yusuke
    Kimura, Hiroyuki
    Okuda, Haruka
    Ono, Masahiro
    Nakamoto, Yuji
    Togashi, Kaori
    Saji, Hideo
    NUCLEAR MEDICINE AND BIOLOGY, 2019, 74-75 : 25 - 31